Bank Of America Corp Black Diamond Therapeutics, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 42,297 shares of BDTX stock, worth $92,207. This represents 0.0% of its overall portfolio holdings.

Number of Shares

42,297

Previous 18,887 123.95%

Holding current value

$92,207

Previous $88,000 107.95%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.2 - $6.58 $98,322 - $154,037	23,410 Added 123.95%	42,297 $183,000
Q2 2024 Aug 14, 2024	BUY	$4.65 - $7.39 $34,930 - $55,513	7,512 Added 66.04%	18,887 $88,000
Q1 2024 May 15, 2024	SELL	$2.67 - $5.74 $121,642 - $261,508	-45,559 Reduced 80.02%	11,375 $57,000
Q4 2023 Feb 14, 2024	BUY	$1.77 - $3.03 $100,751 - $172,473	56,922 Added 474350.0%	56,934 $159,000
Q2 2023 Aug 14, 2023	SELL	$1.43 - $6.18 $18,271 - $78,961	-12,777 Reduced 99.91%	12 $0
Q1 2023 May 12, 2023	SELL	$1.35 - $3.14 $33 - $78	-25 Reduced 0.2%	12,789 $24,000
Q4 2022 Feb 10, 2023	SELL	$1.27 - $2.51 $2,885 - $5,702	-2,272 Reduced 15.06%	12,814 $23,000
Q3 2022 Nov 14, 2022	SELL	$1.68 - $4.01 $58,193 - $138,902	-34,639 Reduced 69.66%	15,086 $25,000
Q2 2022 Aug 12, 2022	SELL	$1.5 - $3.63 $12,771 - $30,905	-8,514 Reduced 14.62%	49,725 $122,000
Q1 2022 May 16, 2022	SELL	$2.66 - $5.61 $2,356 - $4,970	-886 Reduced 1.5%	58,239 $161,000
Q4 2021 Feb 08, 2022	BUY	$5.18 - $8.48 $113,799 - $186,297	21,969 Added 59.13%	59,125 $316,000
Q3 2021 Nov 15, 2021	SELL	$8.46 - $12.42 $81,858 - $120,175	-9,676 Reduced 20.66%	37,156 $314,000
Q2 2021 Sep 13, 2021	BUY	$12.19 - $28.17 $570,882 - $1.32 Million	46,832 New	46,832 $570,000

Others Institutions Holding BDTX

# of Institutions

117

Shares Held

48.8M

Call Options Held

1.84M

Put Options Held

1.93M

View Full List

About Black Diamond Therapeutics, Inc.

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $79.2M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

More about BDTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Black Diamond Therapeutics, Inc. Transaction History